Biological Products, (No Diagnostic Substances)

95 US-listed companies SIC 2836 · all industries

How much this is one bet

39% of the closest matches for a typical Biological Products, (No Diagnostic Substances) company are other Biological Products, (No Diagnostic Substances) companies. That is moderate. The industry moves together to a degree, but individual companies still have plenty of their own story.

How the industry moves

Companies 95
Traded per day $5.3B
Median volatility 76.2%
Median beta vs SPY 1.50
Rate sensitivity -0.16
Volatility sensitivity -0.26

Measured from one year of daily returns. Rate sensitivity is the median correlation between a company's daily return and the daily change in the 10-year Treasury yield: positive means the industry tends to rise on days yields rise. It is a correlation, not a forecast, and a low number over one year is a statement about this year.

On the public record

Shares sold short 1.95B
Median days to cover 10.6
Insider purchases 10
Insider sales 317
Congressional trades 191
Institutions’ reported value $487.06B
Federal contracts $126.0M
Combined revenue as filed $93.39B

The companieslargest 60 by daily turnover

TickerCompanyTraded per dayBetaDays to cover
GILD Gilead Sciences, Inc. $860.7M 0.35 3.2
AMGN Amgen Inc. $860.3M 0.53 4.3
RVMD Revolution Medicines, Inc. $385.4M 1.18 6.4
MRNA Moderna, Inc. $306.2M 1.81 9.2
ARGX argenx SE $251.6M 0.34 4.4
BIIB Biogen Inc. $207.1M 0.34 6.1
NBIX Neurocrine Biosciences, Inc. $184.9M 0.64 3.4
TECH Bio-Techne Corp $170.5M 0.89 2.3
RGEN Repligen Corporation $140.4M 1.21 6.4
EXEL Exelixis, Inc. $129.3M 0.60 8.7
HALO Halozyme Therapeutics, Inc. $129.1M 0.58 5.0
TWST Twist Bioscience Corporation $120.3M 2.67 7.9
KRYS Krystal Biotech, Inc. $94.4M 0.84 10.3
QGEN Qiagen N.V. $91.6M 0.39 3.1
IBRX ImmunityBio, Inc. $82.8M 1.61 15.4
CRSP CRISPR Therapeutics AG $80.6M 1.83 15.6
BNTX BioNTech SE $79.2M 0.92 2.3
PCVX Vaxcyte, Inc. $65.1M 0.91 15.9
CGON CG Oncology, Inc. $59.1M 1.11 14.9
BEAM Beam Therapeutics Inc. $56.8M 2.16 16.1
KYMR Kymera Therapeutics, Inc. $53.9M 0.83 13.9
IOVA Iovance Biotherapeutics, Inc. $53.8M 1.34 4.8
RXRX Recursion Pharmaceuticals, Inc. $51.1M 2.91 13.4
SRRK Scholar Rock Holding Corporation $50.9M 0.95 19.8
TARS Tarsus Pharmaceuticals, Inc. $46.3M 0.61 7.5
RLAY Relay Therapeutics, Inc. $44.4M 1.56 21.6
IMVT Immunovant, Inc. $40.8M 1.35 15.1
ADPT Adaptive Biotechnologies Corporation $40.5M 1.84 5.7
DNLI Denali Therapeutics Inc. $35.8M 1.49 12.4
BCRX BioCryst Pharmaceuticals, Inc. $34.4M 0.62 8.0
REPL Replimune Group, Inc. $32.0M 1.06 4.0
NVAX Novavax, Inc. $32.0M 1.82 14.0
ADMA ADMA Biologics Inc $28.0M 0.80 8.0
KOD Kodiak Sciences Inc $23.2M 1.19 17.5
VCEL Vericel Corporation $20.8M 0.90 11.5
GLUE Monte Rosa Therapeutics, Inc. $18.4M 0.91 14.0
VOR Vor Biopharma Inc. $15.0M 1.52 9.8
TSHA Taysha Gene Therapies, Inc. $14.2M 1.78 17.4
VIR Vir Biotechnology, Inc. $14.1M 1.72 13.6
ALLO Allogene Therapeutics, Inc. $13.8M 2.19 11.9
CADL Candel Therapeutics, Inc. $13.7M 2.01 10.6
IMCR Immunocore Holdings plc $13.6M 0.62 18.8
CGEM Cullinan Therapeutics, Inc. $12.7M 1.33 15.5
RGNX REGENXBIO Inc. $11.6M 1.99 7.8
CABA Cabaletta Bio, Inc. $9.6M 1.84 12.4
SANA Sana Biotechnology, Inc. $9.6M 2.44 18.0
DNA Ginkgo Bioworks Holdings, Inc. Class A $9.3M 3.00 4.3
OTLK Outlook Therapeutics, Inc. $9.0M 0.97 1.0
PRME Prime Medicine, Inc. $8.4M 2.21 13.8
CCCC C4 Therapeutics, Inc. $8.4M 2.02 13.9
SLDB Solid Biosciences Inc. $8.4M 2.09 19.6
STRO Sutro Biopharma, Inc. $8.1M 1.24 5.4
CMPX Compass Therapeutics, Inc. $7.5M 1.24 9.8
OCGN Ocugen, Inc. $7.2M 1.50 23.9
FDMT 4D Molecular Therapeutics, Inc. $7.1M 1.93 22.3
KYTX Kyverna Therapeutics, Inc. $7.1M 2.56 13.3
MGTX MeiraGTx Holdings plc $6.8M 1.65 8.1
HUMA Humacyte, Inc. $5.9M 3.17 3.4
FATE Fate Therapeutics, Inc. $5.8M 1.93 3.3
LENZ LENZ Therapeutics, Inc. $5.8M 1.43 12.5

What “one bet” means, and how it is measured

For every security this site computes its closest matches across the whole market, by one-year daily-return correlation. Cohesion asks a simple question of that: of the ten closest matches for each company in this industry, what share are also in this industry?

A high number means the classification is doing real work — these companies genuinely move together, and the industry is closer to a single position than to a set of independent ones. Trucking, shipping, homebuilders and airlines sit at the top of that measure, which is what anyone who has held two of them would tell you.

A low number means the opposite: the SEC's code groups them, but the market does not. That is worth knowing before treating an industry label as a diversification plan.

Where these numbers come from

What is deliberately absent

No index, no sector return, no performance figure. Aggregating company returns into an industry return would be republishing the licensed price history in a thin disguise, and it would also be wrong — there is no defensible weighting to choose. The statistics here are all invariant to that problem: a median, a correlation, a count, or a sum of filed figures.

All industries, ranked · each company's own page is under security pages.